sources

Health Effects of Cannabis and Cannabinoids: Current State of Evidence and Research Recommendationswith Nih.gov. Accessed 5/13/2021.

Corroon J, Felice JF. Endocannabinoid System and its Modulation by Cannabidiol (CBD)with Alternative Ther Health Medwith 2019; 25 (S2): 6-14.

Cannabidiol (CBD) – What We Know and What We Do Not – Harvard Health Blogwith Harvard Health Blog. Accessed 5/13/2021.

Linares IM, Zuardi AW, Pereira LC, et al. Cannabidiol presents an inverted U-shaped dose response curve in a simulated public speaking testwith Brazilian Journal of Psychiatry. 2019; 41 (1): 9-14.

TV Zanelati, Biojone C, Moreira FA, Guimarães FS, Joca SR. Cannabidiol antidepressant-like effects in rats: possible involvement of 5-HT1A receptorswith Br J PharmacolMe 2010; 159 (1): 122-128.

Office of the Commissioner. FDA approves first drug consisting of an active ingredient derived from marijuana to treat rare and severe forms of epilepsyWith the US Food and Drug Administration. Accessed 5/13/2021.

Elms L, Shannon S, Hughes S, Lewis N. Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Series of Caseswith Journal of Alternative and Complementary Medicine. 2019; 25 (4): 392-397.

Bitencourt RM, Takahashi RN. Cannabidiol as a Therapeutic Alternative for Post-Traumatic Stress Disorder: From Stool Research to Confirmation in Human Trialswith Limits in NeuroscienceMe 2018; 12.

Hurd YL, Spriggs S, Alishayev J, et al. Cannabidiol for reducing the desire and anxiety caused by suggestion in individuals not using drugs with heroin use disorder: A double blind randomized trial controlled by placebowith American Journal of PsychiatryMe 2019; 176 (11): 911-922.

Hurd YL, Yoon M, Manini AF, et al. Early stage in cannabidiol development as a treatment for addiction: Opioid recurrence takes the initial stage of centerwith NeurotherapeuticMe 2015; 12 (4): 807-815.

Bilsland LG, Dick JR, Pryce G, et al. Increased cannabinoid levels from pharmacological and genetic manipulation delay disease progression in SOD1 micewith FASEB JMe 2006; 20 (7): 1003-1005.

Meyer T, Funke A, Münch C, et al. Real-world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasm using tetrahydrocannabinol: cannabidiol (THC: CBD)with BMC NeurolMe 2019; 19 (1): 222.

Russo EB. Cannabinoids in pain management difficult to treatwith Ther Clin Risk ManagementMe 2008; 4 (1): 245-259.

Xu DH, Cullen BD, Tang M, Fang Y. Effectiveness of topical cannabidiol oil in symptomatic relief of lower extremity peripheral neuropathywith Curr Pharm BiotechnologyMe 2020; 21 (5): 390-402.

Weiss L, Zeira M, Reich S, et al. Cannabidiol reduces the incidence of diabetes in non-obese diabetic ratswith AutoimmunityMe 2006; 39 (2): 143-151.

Rajesh M, Mukhopadhyay P, Bátkai S, et al. Cannabidiol alleviates the inflammatory response of endothelial cells caused by high glucose and barrier breakdownwith American Journal of Cardiology-Circulation and Circulatory PhysiologyMe 2007; 293 (1): H610-H619.

Randomized, double-blind, placebo-controlled group, parallel group, 1: 1 and 20: 1 pilot study Report formulated GWP42003: GWP42004 Plus GWP42003 and GWP42004 Only in the treatment of dyslipidemia in subjects with type 2 diabetesWith clinical trials.gov. Accessed 5/13/2021.

Mannucci C, Navarra M, Calapai F, et al. Neurological aspects of medical cannabidiol usewith Drug Targets for CNS Neurol DisorderMe 2017; 16 (5): 541-553.

Malfait AM, Gallily R, Sumariwalla PF, et al. The non-psychoactive ingredient cannabidiol cannabis is an oral therapy against arthritis in arthritis caused by collagen in micewith Proc Natl Acad Sci USAMe 2000; 97 (17): 9561-9566.

Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M. Cannabinoids as new anti-inflammatory drugswith The future of Med ChemMe 2009; 1 (7): 1333-1349.

Blake DR, Robson P, Ho M, Jubb RW, McCabe CS. Preliminary evaluation of the efficacy, tolerance and safety of a cannabis-based drug (Sativex) in the treatment of pain caused by rheumatoid arthritiswith RheumatologyMe 2006; 45 (1): 50-52.

Hunter D, Oldfield G, Tich N, Messenheimer J, Sebree T. Synthetic transdermal cannabidiol for the treatment of knee pain due to osteoarthritiswith Osteoarthritis and CartilageMe 2018; 26: S26.